Effects of CD26 in Parthenogenetically Activated Porcine Embryos |
Park, Mi-Ryung
(Animal Biotechnology Division, National Institute of Animal Science, RDA)
Im, Ji-Hyun (Animal Biotechnology Division, National Institute of Animal Science, RDA) Chung, Hak-Jae (Animal Biotechnology Division, National Institute of Animal Science, RDA) Kim, Kyong-Woon (Animal Biotechnology Division, National Institute of Animal Science, RDA) Byun, Sung June (Animal Biotechnology Division, National Institute of Animal Science, RDA) Hwang, Seongsoo (Animal Biotechnology Division, National Institute of Animal Science, RDA) Im, Gi-Sun (Animal Biotechnology Division, National Institute of Animal Science, RDA) |
1 | Gaetaniello L, Fiore M, de Filippo S, Pozzi N, Tmasi S and Pignata C. 1998. Occupancy of dipeptidyl peptidase IV activates an associated tyrosine kinase and triggers an apoptotic signal in human hepatocarcinoma cells. Hepatology 27:934-942. DOI |
2 | Gorrell MD. 2005. Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders. Clin Sci. 108: 277-292. DOI |
3 | Gorrell MD and Yu DMT. 2005. Diverse functions in a conserved structure: the dipeptidyl peptidase IV gene family. In Trends in Protein Research (Robinson, JW, ed.), pp.1-78. Nova Science Publishers, Inc., New York. |
4 | Langner J and Ansorge S. 2002. Ectopeptidases:CD13/Aminopeptidase N and CD26 in Medicine and Biology. Kluwer/Plenum, New York. |
5 | Hanski C, Huhle T and Reutter W. 1986. Involvement of plasma membrane dipeptidyl peptidase IV in fibronectin-mediated adhesion of cells on collagen. Biol. Chem. Hoppe-Seyler. 366:1169-1176. |
6 | Heike M, Mobius U, Knuth A, Meuer S and Meyer zum Buschenfelde, KH. 1988. Tissue distribution of the T cell activation antigen Ta1. Serogogical, immunohistochmical and biochemical investigations. Clin. Exp. Immunol. 74: 431-434. |
7 | Imai K, Maeda M, Fujiwara H, Kariya M, Takakura K, Kanzaki H and Mori T. 1992. Dipeptidyl peptidase IV as a differentiation marker of the human endometrial glandular cells. Hum Reprod. 7: 1189-1194. DOI |
8 | Loster K, Zeilinger K, Schupppan D and Reutter W. 1995. The cystein-rich region of dipeptiyl peptidase IV (CD26) is the collagen-binding site. Biochem. Biophys. Res. Commun. 217:341-348. DOI |
9 | Mizutani S, Sumi S, Narita O and Tomoda Y. 1985. Purification and properties of human placental dipeptidyl peptidase IV. Nippon Sanka Fujinka Gakkai Zashi. 37: 769-775. |
10 | Nemoto E, Sugawara S, Takada H, Shoji S and Horiuch H. 1999. Increase of CD26/dipeptidyl peptidase IV expression on human gingival fibroblasts upon stimulation with cytokines and bacterial components. Infect. Immun. 67:6225-6233. |
11 | Nishikawa M, Itakura A, Ito M, Takeuchi M, Sato Y, Kajiyama H, Mizutani S and Kikkawa F. 2005. Changes in placental dipeptidyl peptidase IV in preeclampsia with intrauterine growth restriction. Horm. Metab. Res. 37:408-413. DOI |
12 | Umadevi VW, Michelle McGroarty and Asal H. 2005. Dipeptidyl peptidase inhibits malignant phenotype of prostate cancer cells by blocking basic fibroblast growth factor signaling pathway. Cancer Res. 65:1325-1334. DOI |
13 | Shimomura Y, Ando H, Furugori K, Kajiyama H, Suzuki M, Iwase A, Mizutani S and Kikkawa F. 2006. Possible involvement of crosstalk cell-adhesion mechanism by endometrial CD26/dipeptidyl peptidase IV and embryonal fibronectin in human blastocyst implantation. Mol. Hum. Reprod. 12:491-495. DOI |